• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA clears new patient monitor from GE HealthCare

FDA clears new patient monitor from GE HealthCare

April 29, 2024 By Sean Whooley

GE HealthCare Portrait VSM vital signs monitor
The Portrait VSM vital signs monitor. [Image courtesy of GE HealthCare]
GE HealthCare (Nasdaq: GEHC) announced today that it received FDA 510(k) clearance for its Portrait VSM vital signs monitor.

Portrait VSM provides clinicians with an accurate view of patient vital signs to support timely clinical decisions. It utilizes the SuperSTAT non-invasive blood pressure algorithm to provide precise and accurate measurement readings. Through wireless connectivity and seamless EMR integration, the monitor centers around workflow efficiency. It offers customized early warning scores (EWS) and enables care teams to focus on patient care by automating routine tasks.

The system builds on the GE HealthCare family of Portrait monitoring solutions. It can connect with the latest iteration of the Portrait Mobile wireless, wearable continuous monitoring system as well. Using a single click of a barcode scanner, Portrait VSM automatically imports the patient demographic data and a snapshot of the patient’s continuously monitored data, including respiratory rate, oxygen saturation and pulse rate, from Portrait Mobile.

GE HealthCare says this ecosystem enables accurate charting and reduces delays from manual data entry. The uninterrupted flow of data and vital sign measurement also helps detect patient decline as it happens for timely interventions.

Portrait VSM combines standard spot check capability with continuous patient monitoring.

“We remain focused on tackling healthcare’s biggest challenges and driving further efficiencies for care teams through new patient monitoring technology. To help ease the way to more confident care, Portrait VSM offers the clinical performance and capabilities that care teams can trust, so they can spend more valuable time with their patients,” said Neal Sandy, GM, monitoring solutions, GE HealthCare. “With the addition of Portrait VSM, we are excited about this next step for the Portrait Ecosystem that was designed to support the right level of patient monitoring in observational care through a single, unified workflow.”

Filed Under: 510(k), Food & Drug Administration (FDA), Health Technology, Hospital Care, Patient Monitoring, Regulatory/Compliance Tagged With: FDA, GE Healthcare

More recent news

  • Retired Stryker leader Tim Scannell dies at 62
  • HighLife raises more than $90M to advance its TMVR system
  • UltraSight raises $24M in Series B2 to scale AI-guided cardiac ultrasound technology
  • Convatec launches new hydrophilic option for self-catheterization
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy